- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07303400
Assessment of the Effectiveness of a Prototype Diagnostic System of Bacterial Respiratory Infections Based on Real-time Sequencing
March 24, 2026 updated by: Stefano Gaiarsa, Fondazione IRCCS Policlinico San Matteo di Pavia
The objective of this project is to test the efficiency of a novel developed protocol for direct real-time metagenomic sequencing of Lower Respiratory Infection samples.
The investigators aim to assess the anticipation time, compared to the traditional culturing methods and the accuracy, compared to gold standards
Study Overview
Status
Active, not recruiting
Conditions
Study Type
Observational
Enrollment (Estimated)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pavia
-
Pavia, Pavia, Italy, 27100
- Fondazione IRCCS Policlinico San Matteo di Pavia
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Patients tested for Lower Respiratory tract infections using bronchoalveolar lavage samples
Description
Inclusion Criteria:
- Willingness and ability to provide written informed consent prior to performing the study procedures
- Patients older than 18 years of age
- Suspected bacterial Lower Respiratory Infection (LRI)
- 500µL of lower respiratory tract sample (e.g. Bronchoalveolar lavage) are available after the routine diagnostic procedures are over
Exclusion Criteria:
- Low amount of leftover specimen
- Complex diagnosis: clinicians could require further analysis after the first diagnosis is produced
- A sample of the same patient has been already included in the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
test positivity
Time Frame: Baseline
|
assess the effectiveness in detection of positive (Gram+ vs Gram- vs mixed culture samples) vs negative samples
|
Baseline
|
|
species identification
Time Frame: Baseline
|
Assess the effectiveness in recognizing the correct bacterial species
|
Baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
anticipation time
Time Frame: Baseline
|
Measure the anticipation time of the novel protocol vs gold standard (culturing)
|
Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 9, 2025
Primary Completion (Actual)
December 31, 2025
Study Completion (Estimated)
May 1, 2026
Study Registration Dates
First Submitted
December 2, 2025
First Submitted That Met QC Criteria
December 18, 2025
First Posted (Actual)
December 24, 2025
Study Record Updates
Last Update Posted (Actual)
March 25, 2026
Last Update Submitted That Met QC Criteria
March 24, 2026
Last Verified
August 1, 2025
More Information
Terms related to this study
Other Study ID Numbers
- ASAP
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lower Resp Tract Infection
-
University of SouthamptonNot yet recruitingLower Resp Tract Infection
-
American University of Beirut Medical CenterNot yet recruiting
-
Duke UniversityNational Institute of Allergy and Infectious Diseases (NIAID)Recruiting
-
Centre Hospitalier Universitaire VaudoisCompletedLower Resp Tract InfectionSwitzerland
-
BioFire Diagnostics, LLCCompletedLower Resp Tract InfectionUnited States
-
Assistance Publique - Hôpitaux de ParisUnknownLower Resp Tract Infection | Human Metapneumovirus InfectionFrance
-
Duke UniversityCompletedCOVID-19 | SARS-CoV-2 | Lower Resp Tract Infection | Coronavirus | Influenza -Like Illness | Upper Resp Tract InfectionUnited States
-
University Hospital, CaenCompletedLower Resp Tract Infection | Ultrasound Therapy; ComplicationsFrance
-
Penn State UniversityUniversity of GhanaNot yet recruitingUpper Resp Tract InfectionGhana
-
Centre Hospitalier Universitaire VaudoisUniversity of Witwatersrand, South Africa; Ecole Polytechnique Fédérale de... and other collaboratorsCompletedPneumonia | Tuberculosis | Lower Resp Tract InfectionMali, Benin, South Africa